Dupilumab reduces systemiccorticosteroid use in children with uncontrolledmoderate-to-severe asthma regardless of priorexacerbation history
Ducharme FM, Sher LD, Hamelmann E, de Mir I, Xia C, Gall R, Ledanois O, Jacob-Nara JA, Sacks H, Rowe PJ, Deniz Y (2023)
Respirology 28(Suppl. 4): 342.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Ducharme, Francine M.;
Sher, Lawrence D.;
Hamelmann, EckardUniBi;
de Mir, Ines;
Xia, Changming;
Gall, Rebecca;
Ledanois, Olivier;
Jacob-Nara, Juby A.;
Sacks, Harry;
Rowe, Paul J.;
Deniz, Yamo
Erscheinungsjahr
2023
Serien- oder Zeitschriftentitel
Respirology
Band
28
Ausgabe
Suppl. 4
Seite(n)
342
Konferenz
27th Congress of the Asian Pacific Society of Respirology
Konferenzort
Singapore
Konferenzdatum
2023-11-16 – 2023-11-19
ISSN
1323-7799
eISSN
1440-1843
Page URI
https://pub.uni-bielefeld.de/record/2987958
Zitieren
Ducharme FM, Sher LD, Hamelmann E, et al. Dupilumab reduces systemiccorticosteroid use in children with uncontrolledmoderate-to-severe asthma regardless of priorexacerbation history. Respirology . 2023;28(Suppl. 4):342.
Ducharme, F. M., Sher, L. D., Hamelmann, E., de Mir, I., Xia, C., Gall, R., Ledanois, O., et al. (2023). Dupilumab reduces systemiccorticosteroid use in children with uncontrolledmoderate-to-severe asthma regardless of priorexacerbation history. Respirology , 28(Suppl. 4), 342. https://doi.org/10.1111/resp.14618
Ducharme, Francine M., Sher, Lawrence D., Hamelmann, Eckard, de Mir, Ines, Xia, Changming, Gall, Rebecca, Ledanois, Olivier, et al. 2023. “Dupilumab reduces systemiccorticosteroid use in children with uncontrolledmoderate-to-severe asthma regardless of priorexacerbation history”, Respirology , 28 (Suppl. 4): 342.
Ducharme, F. M., Sher, L. D., Hamelmann, E., de Mir, I., Xia, C., Gall, R., Ledanois, O., Jacob-Nara, J. A., Sacks, H., Rowe, P. J., et al. (2023). Dupilumab reduces systemiccorticosteroid use in children with uncontrolledmoderate-to-severe asthma regardless of priorexacerbation history. Respirology 28, 342.
Ducharme, F.M., et al., 2023. Dupilumab reduces systemiccorticosteroid use in children with uncontrolledmoderate-to-severe asthma regardless of priorexacerbation history. Respirology , 28(Suppl. 4), p 342.
F.M. Ducharme, et al., “Dupilumab reduces systemiccorticosteroid use in children with uncontrolledmoderate-to-severe asthma regardless of priorexacerbation history”, Respirology , vol. 28, 2023, pp. 342.
Ducharme, F.M., Sher, L.D., Hamelmann, E., de Mir, I., Xia, C., Gall, R., Ledanois, O., Jacob-Nara, J.A., Sacks, H., Rowe, P.J., Deniz, Y.: Dupilumab reduces systemiccorticosteroid use in children with uncontrolledmoderate-to-severe asthma regardless of priorexacerbation history. Respirology . 28, 342 (2023).
Ducharme, Francine M., Sher, Lawrence D., Hamelmann, Eckard, de Mir, Ines, Xia, Changming, Gall, Rebecca, Ledanois, Olivier, Jacob-Nara, Juby A., Sacks, Harry, Rowe, Paul J., and Deniz, Yamo. “Dupilumab reduces systemiccorticosteroid use in children with uncontrolledmoderate-to-severe asthma regardless of priorexacerbation history”. Respirology 28.Suppl. 4 (2023): 342.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar